Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sartorius | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Sartorius

Dominique Baly has been appointed president of Sartorius’ group laboratory business, responsible for cross-divisional management of marketing, sales and service.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dominique Baly has been appointed president of Sartorius’ group laboratory business, responsible for cross-divisional management of marketing, sales and service. Mr. Baly reports to the chief executive officer and is a member of the group executive committee that includes six executives of Sartorius AG and the subgroup Sartorius Stedim Biotech.

“With Dominique Baly, we are gaining an exceptionally experienced and successful manager for our team. He will give our laboratory business decisive momentum in this fast-evolving market environment to define the future positioning for significant growth,” said chief executive officer and executive board chairman, Dr. Joachim Kreuzburg.

Mr. Baly has more than 35 years of sales and managerial experience. He joins the company from Millipore Corp., which was acquired by Merck KGaA in 2010. From 2005 to 2008, he was president of the bioscience division. In 2009, he became chief executive officer of Accelerator Sciences LLC, a U.S. investment firm.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters